27 research outputs found

    Protective effects of dantrolene and methylprednisolone against spinal cord injury-induced early oxidative damage in rabbit bladder: A comparative experimental study

    Get PDF
    Conclusions. Dantrolene and MP may have potential benefits against oxidative damage in the bladder after SCIs because of their anti-inflammatory and antioxidant effects. In particular, the combined use of DNT and MP at different doses can be considered a treatment strategy

    Sustained Na<sup>+</sup>/H<sup>+</sup> exchanger activation promotes gliotransmitter release from reactive hippocampal astrocytes following oxygen-glucose deprivation

    Get PDF
    Hypoxia ischemia (HI)-related brain injury is the major cause of long-term morbidity in neonates. One characteristic hallmark of neonatal HI is the development of reactive astrogliosis in the hippocampus. However, the impact of reactive astrogliosis in hippocampal damage after neonatal HI is not fully understood. In the current study, we investigated the role of Na +/H+ exchanger isoform 1 (NHE1) protein in mouse reactive hippocampal astrocyte function in an in vitro ischemia model (oxygen/glucose deprivation and reoxygenation, OGD/REOX). 2 h OGD significantly increased NHE1 protein expression and NHE1-mediated H+ efflux in hippocampal astrocytes. NHE1 activity remained stimulated during 1-5 h REOX and returned to the basal level at 24 h REOX. NHE1 activation in hippocampal astrocytes resulted in intracellular Na+ and Ca2+ overload. The latter was mediated by reversal of Na+/Ca2+ exchange. Hippocampal astrocytes also exhibited a robust release of gliotransmitters (glutamate and pro-inflammatory cytokines IL-6 and TNFα) during 1-24 h REOX. Interestingly, inhibition of NHE1 activity with its potent inhibitor HOE 642 not only reduced Na+ overload but also gliotransmitter release from hippocampal astrocytes. The noncompetitive excitatory amino acid transporter inhibitor TBOA showed a similar effect on blocking the glutamate release. Taken together, we concluded that NHE1 plays an essential role in maintaining H + homeostasis in hippocampal astrocytes. Over-stimulation of NHE1 activity following in vitro ischemia disrupts Na+ and Ca2+ homeostasis, which reduces Na+-dependent glutamate uptake and promotes release of glutamate and cytokines from reactive astrocytes. Therefore, blocking sustained NHE1 activation in reactive astrocytes may provide neuroprotection following HI. © 2014 Cengiz et al

    TrkB Receptor Agonist 7, 8 Dihydroxyflavone Triggers Profound Gender-Dependent Neuroprotection in Mice After Perinatal Hypoxia and Ischemia

    No full text
    In this study, we investigated the effects of a bioactive high-affinity TrkB receptor agonist 7,8-dihydroxyflavone (7,8 DHF) on neonatal brain injury in female and male mice after hypoxia ischemia (HI). HI was induced by exposure of postnatal day 9 (P9) mice to 10% O-2 for 50 minutes at 37 degrees C after unilateral ligation of the left common carotid artery. Animals were randomly assigned to HI-vehicle control group [phosphate buffered saline (PBS), intraperitoneally (i.p.)] or HI + 7,8 DHF-treated groups (5 mg/kg in PBS, i.p at 10 min, 24 h, or with subsequent daily injections up to 7 days after HI). The HI-vehicle control mice exhibited neuronal degeneration in the ipsilateral hippocampus and cortex with increased Fluoro-Jade C positive staining and loss of microtubule associated protein 2 expression. In contrast, the 7,8 DHF-treated mice showed less hippocampal neurodegeneration and astrogliosis, with more profound effects in female than in male mice. Moreover, 7,8 DHF-treated mice improved motor learning and spatial learning at P30-60 compared to the HI-vehicle control mice. Diffusion tensor imaging of ex vivo brain tissues at P90 after HI revealed less reduction of fractional anisotropy values in the ipsilateral corpus callosum of 7,8 DHF-treated brains, which was accompanied with better preserved myelin basic protein expression and CA1 hippocampal structure. Taken together, these findings strongly suggest that TrkB agonist 7,8 DHF is protective against HI-mediated hippocampal neuronal death, white matter injury, and improves neurological function, with a more profound response in female than in male mice

    Glutamate and pro-inflammatory cytokine release from hippocampal astrocytes following OGD/REOX.

    No full text
    <p><b>A.</b> Glutamate release in hippocampal astrocyte cultures was determined at 2(1 µM) or TBOA (100 µM) was present during REOX only. Data are mean ± SEM. N of 4 cultures were for all groups except for normoxia (n = 5). *p<0.05 vs. normoxic control, # p<0.05 vs. corresponding untreated. ND: not detectable. <b>Inset:</b> The reversal potential for the glutamate transport was plotted as a function of [Na<sup>+</sup>]<sub>i</sub>. The known values for [Na]<sub>o</sub>, [H]<sub>o</sub>, [H]<sub>i</sub> and [K]<sub>o</sub> at baselines were used along with an assumed value for [Glu]<sub>o</sub> of 0.01 µM, [Glu]<sub>i</sub> of 5 mM and [K]<sub>i</sub> of 70 mM. <b>B–D</b>. Release of innate immune cytokines in the culture medium of hippocampal astrocytes. HOE 642 (1 µM) was present during normoxia or REOX treatment. IL-1β (<b>B</b>) IL-6 (<b>C</b>), or TNF-α (<b>D</b>) were normalized to cell lysate protein and expressed as pg/mg protein. Data are mean ± SEM (n = 3). ND: not detectable. *p<0.05 vs. normoxic control. # p<0.05 vs. corresponding untreated.</p

    Changes of [Na<sup>+</sup>]<sub>i</sub> and [Ca<sup>2+</sup>]<sub>i</sub> in hippocampal astrocytes following OGD/REOX.

    No full text
    <p><b>A.</b> [Na<sup>+</sup>]<sub>i</sub> in hippocampal astrocyte cultures was determined with Sodium Green dye at 2 h normoxia or after 2 h OGD followed by 0, 1, 5, or 24 h REOX. HOE 642 (1 µM) was present during REOX only. Data are mean ± SEM. The values of ∼10 cells from each coverslip/culture were averaged. N of 3 cultures were for all groups except for normoxia, 0 h REOX, and 24 h REOX+HOE 642 (n = 4) or.5 h REOX and 24 h REOX (n = 5). *p<0.05 vs. normoxic control, # p<0.05 vs. corresponding untreated. <b>B.</b> [Ca<sup>2+</sup>]<sub>i</sub> in hippocampal astrocytes following OGD/REOX. [Ca<sup>2+</sup>]<sub>i</sub> in hippocampal astrocyte cultures was determined at 2 h normoxia or after 2 h OGD followed by 0, 1, 3, or 5 h REOX using fura-2 AM. HOE 642 (1 µM) or SEA 0400 (1 µM) was present during REOX only. The values of ∼10 cells from each coverslip/culture were averaged. Data are expressed as mean ± SEM. N of 4 cultures were for normoxia and the rest of other conditions were n of 3 cultures. *p<0.05 vs. normoxic control, # p<0.05 vs. corresponding untreated.</p

    Increased NHE1 activity in hippocampal astrocytes following OGD/REOX.

    No full text
    <p><b>A.</b> pH<sub>i</sub> changes were determined by BCECF-AM dye in astrocytes subjected to NH<sub>4</sub><sup>+</sup>/NH<sub>3</sub> prepulse-mediated acid-loading. Either normoxic astrocytes (left panel) or astrocytes at 2 h OGD (right panel) were exposed to 30 mM NH<sub>4</sub>Cl<sub>3</sub> (<b>a–c</b>), then returned to standard HCO<sub>3</sub><sup>–</sup>free HEPES-MEM solution (<b>c–e</b>). After an initial acidification, pH<sub>i</sub> recovery followed (<b>d–e</b>). The pH recovery rates were determined at ∼ 6.5 to normalize for the allosteric regulation of H<sup>+</sup> on NHE1 activity. A slope of the pH<sub> i</sub> changes following the prepulse was calculated as pH<sub>i</sub> recovery rate (solid or dashed line). For HOE 642 treatment, the drug was present throughout the experiment. <b>B.</b> pH<sub>i</sub> (left panel) and pH<sub>i</sub> recovery rates (right panel) were summarized under normoxic control, 2 h OGD, or 1, 5, or 24 h REOX conditions. <b>C.</b> Summary data of NHE1-mediated recovery rates under normoxic and OGD/REOX conditions. The values of ∼20 cells from each coverslip/culture were averaged. The n values were the number of cultures under each condition and indicated as normoxia (9), normoxia+HOE 642 (6), 0 REOX (5), 0 REOX+HOE 642 (4), 1 h REOX (3), 1 h REOX+HOE 642 (4), 5 h REOX (5), 5 h REOX+HOE 642 (4), 24 h REOX (4) and 24 h REOX+HOE 642 (3). Data are expressed as mean ± SEM. *p<0.05 vs. corresponding untreated. # p<0.05 vs. corresponding untreated.</p

    Minimal cell death of reactive astrocytes after OGD/REOX.

    No full text
    <p>Hippocampal astrocytes were grown on 24 well culture dishes and subjected to 2(1 µM) was present only during REOX. At the end of REOX, cells were loaded with calcein-AM (green) and PI (red). <b>A</b>. Representative images of live (calcein positive) and dead (PI positive) cells of normoxia (a, à), 5 h REOX (b, b`), 5 h REOX+HOE 642 (c, c`), 24 REOX (d, d`) or 24 REOX+HOE 642 (e, è). <b>B</b>. Summary of reactive astrocyte death from six wells from each experimental condition. Data are mean ± SEM. n = 6.</p

    Pro-inflammatory cytokine release from LME-treated hippocampal astrocyte cultures following OGD/REOX.

    No full text
    <p>Release of innate immune cytokines was detected in the culture medium of hippocampal astrocytes at 2(1 µM) was present during normoxia or REOX treatment (with 5 mM LME). IL-1β (<b>A</b>), IL-6 (<b>B</b>), TNF-α (<b>C</b>). Cytokine content was normalized to cell lysate protein and expressed as pg/mg protein. Data are mean ± SEM (n = 3). *p<0.05 vs. normoxic control. # p<0.05 vs. corresponding untreated, ND: not detectable.</p
    corecore